Trade Names | |
Synonyms | |
Status | |
Molecule Category | Free-form |
ATC | S01EE01 |
UNII | 6Z5B6HVF6O |
EPA CompTox | DTXSID1041057 |
InChI Key | GGXICVAJURFBLW-CEYXHVGTSA-N | |
---|---|---|
Smiles | ||
InChI |
|
Property Name | Value | |
---|---|---|
Molecular Formula | C26H40O5 | |
Molecular Weight | 432.6 | |
AlogP | 4.19 | |
Hydrogen Bond Acceptor | 5.0 | |
Hydrogen Bond Donor | 3.0 | |
Number of Rotational Bond | 13.0 | |
Polar Surface Area | 86.99 | |
Molecular species | NEUTRAL | |
Aromatic Rings | 1.0 | |
Heavy Atoms | 31.0 |
Mechanism of Action | Action | Reference | |
---|---|---|---|
Prostanoid FP receptor agonist | AGONIST | FDA |
Protein: Prostanoid FP receptor Description: Prostaglandin F2-alpha receptor Organism : Homo sapiens P43088 ENSG00000122420 |
||||
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | ||
---|---|---|---|---|---|---|---|
Ion channel
Other ion channel
Pore-forming toxins (proteins and peptides)
|
- | - | - | - | 11 | ||
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 12900 | - | - | - |
Resources | Reference | |
---|---|---|
ChEBI | 6384 | |
ChEMBL | CHEMBL1051 | |
DrugBank | DB00654 | |
DrugCentral | 1551 | |
FDA SRS | 6Z5B6HVF6O | |
Human Metabolome Database | HMDB0014792 | |
Guide to Pharmacology | 1961 | |
KEGG | D00356 | |
PubChem | 5311221 | |
SureChEMBL | SCHEMBL24698 | |
ZINC | ZINC000012468792 |